|
|
||||||||
From 1 Department of Microbiology, Immunology, and Parasitology, Louisiana State University (LSU) Health Sciences Center, and 3 Department of Ophthalmology, LSU Eye Center, New Orleans.
| Abstract |
|---|
|
|
|---|
METHODS. Contact lenses with Staphylococcus aureus were applied to scarified rabbit eyes. The colony-forming units (CFU) per cornea or lens were determined and pathology was scored by slit-lamp examination (SLE). The bactericidal activity was measured by incubating bacteria with rabbit tears or PLA2 at 33° or 37°C. Radiolabeled S. aureus was incubated with PLA2 or tears to quantify the release of a membrane component that was identified by thin-layer chromatography. Inhibitors of these reactions were also analyzed.
RESULTS. Application of Staphylococcus, on contact lenses, to
rabbit corneas resulted in bacterial killing and limited inflammation.
Incubation of tears and bacteria (1:1; v/v) in tryptic soy broth at
33°C decreased CFU approximately 4 logs. Tears (
30 µl) or PLA2
(
30 U) incubated with bacteria in phosphate-buffered saline
were bactericidal. PLA2 (
0.2 U) or tears (
2 µl) cleaved bacterial
membranes, liberating arachidonic acid. Spermidine or tetracaine
inhibited cleavage of bacterial membranes by tears or PLA2 and
spermidine promoted bacterial survival and growth in tears. Tears (60
µl) killed >99% of the bacterial inoculum, whereas bacteria
incubated in tears plus spermidine approximately doubled in number.
CONCLUSIONS. PLA2 in rabbit tears kills Staphylococcus by hydrolyzing bacterial membranes to release arachidonic acid. Spermidine and tetracaine inhibited PLA2 activity and spermidine protected Staphylococcus from PLA2 in rabbit tears.
| Introduction |
|---|
|
|
|---|
Weinrauch et al.8 and Dominiecki and Weiss9 have reported that phospholipase A2 (PLA2) from leukocytes can rapidly kill Staphylococcus aureus. This enzyme cleaves arachidonic acid from the bacterial membrane10 11 and, when such cleavage is extensive, membrane damage activates autolytic bacterial enzymes that destroy the bacterial cell wall.12 Such bactericidal activity of phospholipase has been reported to be active in human tears and has been suggested to be a part of the host defense system.13
S. aureus, the leading cause of keratitis in many human populations14 15 16 17 can cause severe keratitis in rabbits after intrastromal injection of log phase bacteria into the cornea.18 Unlike Pseudomonas, which can topically infect and replicate extensively in a scratched rabbit cornea,19 S. aureus fails to replicate in a scarified rabbit cornea after topical inoculation.20 The fate of the inoculated bacteria has not been analyzed, but the likelihood is that the host defense system either directly kills these bacteria or removes the organisms from the corneal surface. The defensive mechanism active in the rabbit tear film has not been analyzed.
Inhibition of the activity of host defense molecules such as phospholipase A2 could alter the ability of tears to kill bacteria, and in doing so help elucidate the mechanisms that are important to host defense. Inhibitors of phospholipase A2 include spermidine, a polyamine, and topical anesthetics such as tetracaine.21 22 Spermidine indirectly inhibits the activity of phospholipase A2 by sterically hindering the interaction with its substrate.21 Two hypotheses have been proposed concerning the inhibition of phospholipase A2 by tetracaine.22 One hypothesis is the possibility that tetracaine interacts with the substrate of phospholipase A2. The second hypothesis involves the binding of the anesthetic to phospholipase A2 possibly displacing Ca2+ from the enzyme.
The present study was undertaken to determine the mechanisms that prevent bacterial replication after topical Staphylococcus inoculation of the rabbit cornea. The findings emphasize the importance of phospholipase A2 as a defensive bactericidal molecule of the rabbit tear film and illustrate the ability of a phospholipase A2 inhibitor to compromise this potent ocular defense.
| Materials and Methods |
|---|
|
|
|---|
Contact Lenses
Soft contact lenses (Surevue, Type IV: 42% etafilcon A, 58%
water; Vistakon, Johnson & Johnson, Jacksonville, FL) were placed into
1.5 ml of log phase bacteria (8.0 log colony-forming units [CFU]/ml)
in TSB. After 1 hour at room temperature, the lenses were rinsed in
phosphate-buffered saline (PBS; 0.1 M phosphate, 0.85% NaCl, pH 7.0)
and three lenses, selected at random, were assayed to determine the
number of bacteria bound. Lenses were assayed by homogenizing each in
sterile PBS (3.0 ml), diluting the homogenate in PBS and inoculating
the homogenate and dilutions onto tryptic soy agar plates (TSA; Difco
Laboratories). The plates were incubated at 37°C for 24 hours, and
the colony count was used to calculate the log number of bacteria per
lens. Approximately 7.0 log CFU were bound to each lens. Lenses to be
used as controls free of bacteria were placed into the sterile PBS and
then aseptically rinsed with PBS.
Rabbits
New Zealand White rabbits (2.03.0 kg) used in these studies
were maintained in accordance with the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research.
Inoculation of Rabbit Eyes
Rabbits were anesthetized by SC injection of a 1:5 mixture of
100 mg/ml xylazine (Rompun; Miles Laboratories, Shawnee, KS) and 100
mg/ml ketamine hydrochloride (Ketaset; Bristol Laboratories, Syracuse,
NY). One drop of proparacaine hydrochloride (0.5% Alcaine; Alcon
Laboratories, Fort Worth, TX) was instilled into each eye just before
starting the inoculation procedure. Corneas were scarified by making
three horizontal scratches (
8 mm long) with a 22-gauge needle.
Contact lenses were then placed onto the eyes under the nictitating
membrane and a lateral tarsorrhaphy was performed, as described
previously.19
Quantification of S. aureus per Contact Lens or
Cornea
Rabbits were killed by intravenous injection of sodium
pentobarbital solution (100 mg/ml; The Butler Co., Columbus, OH) at
either 24 or 48 hours after inoculation (n = 4 corneas
per time point). Contact lenses were aseptically removed and cultured
as described above. Corneas were aseptically removed, dissected, and
homogenized as previously described.18
23
24
Corneal
homogenates were serially diluted in sterile PBS, aliquots (0.1 ml)
were inoculated onto TSA, and the plates were incubated at 37°C for
24 hours. Colonies were counted, and CFUs per cornea were expressed as
log values.
Slit-Lamp Examination
Ocular pathology was graded by slit-lamp examination (SLE) with
a Topcon S15D slit-lamp biomicroscope (Koaku Kikai K.K., Tokyo,
Japan) using a scoring system that has been previously
described.27
Seven parameters were scored on a scale of 0
(absent) to 4 (severe), including conjunctival injection, conjunctival
chemosis, corneal infiltrate, corneal edema, fibrin in the anterior
chamber, hypopyon, and iritis. Two masked observers performed all SLE
scoring. Rabbit eyes were examined at 8, 24, 48, and 72 hours after
inoculation.
Collection of Rabbit Tears
Capillary tubes were placed into the cul-de-sac of normal
rabbits and allowed to collect 5 to 10 µl of tears. Tears (1000 µl)
from two collections per day from 8 to 10 rabbits were pooled and
frozen in aliquots at -70°C until assayed.
Bactericidal Assay of Rabbit Tears
In initial assays, tears (2590 µl) were mixed in a 1:1 (v/v)
ratio with log phase bacteria in TSB (
7.0 log CFU, initial
concentration) and incubated at either 33° or 37°C for up to 24
hours. Optimal bacterial growth is seen at 37°C, whereas the normal
temperature of the rabbit corneal surface is
33°C.28
In subsequent assays, the bacteria were
grown in M9 medium, centrifuged to a pellet, and then resuspended in
PBS. Bacteria (100200 CFU in 15 µl) were mixed with rabbit tears
(160 µl), and the reactions were incubated at 33°C for 4 hours.
Bacteria in PBS were also incubated with pure porcine pancreatic PLA2
(236 U; Sigma Chemical Co., St. Louis, MO) in Tris-HCl buffer (pH
7.5) and calcium chloride (CaCl2; 2 mM) for 4
hours at 33°C. Aliquots were inoculated onto TSA plates or diluted in
PBS and then inoculated onto TSA plates. The log number of CFUs was
determined from the colony count after 24 to 48 hours of incubation.
Radioactive Labeling of S. aureus
S. aureus was radioactively labeled based on a
modification of the procedure described by Dominiecki and
Weiss.9
S. aureus strain 8325-4 was grown
overnight in M9 medium with amino acids. An aliquot (200 µl) of these
bacteria was subcultured in M9 (20 ml) with 0.5 µCi/ml of
14C-labeled oleic acid (100 µl; specific
activity of 55 mCi/mM; ICN Biomedicals, Irvine, CA) and incubated at
37°C for 2.5 hours. After incubation, the bacteria were centrifuged
to a pellet. The supernatant was removed, and the bacterial pellet was
resuspended in TSB and then incubated for 30 minutes at 37°C. The
labeled bacteria were washed in 1% bovine serum albumin (BSA; Sigma)
and then resuspended in PBS. Bacteria were stored at -70°C until
needed for use.
PLA2 Radioactivity Assay
A modification of the procedure of Wright et al.29
was used to assay PLA2 activity. Radiolabeled bacteria (
1 x
106 CFU with 5700 cpm in 20 µl) were incubated
with PLA2 in Tris-HCl buffer (pH 7.5) or rabbit tears, both with 1 mM
CaCl2, in a total volume of 250 µl at 33°C
for 30 minutes. Reactions were terminated by adding 250 µl of
ice-cold 0.5% BSA. An aliquot (50 µl) of stationary phase
nonradiolabeled S. aureus culture was added and the samples
were centrifuged in a microfuge to pellet the bacteria. Nonradioactive
S. aureus were added to increase the size of the subsequent
bacterial pellet. Reactions with pure PLA2 were centrifuged at 6000 rpm
for 2 minutes and reactions with rabbit tears were centrifuged at 6000
rpm for 6 minutes. An aliquot of supernatant (200 µl) was used to
quantify, by liquid scintillation counting, the products of hydrolysis.
When inhibitors were tested, they were added to the reaction mixtures
just before incubation at 33°C.
Thin-Layer Chromatography of Radioactivity Assay Samples
The supernatants of reactions of PLA2 or tears with
14C-oleic acid labeled Staphylococcus
were pooled. The pooled samples (2.75 ml) were filtered through a
0.22-µm syringe filter (Fisher Scientific, Pittsburgh, PA) to remove
any remaining bacteria. Aliquots of the filtrate (200 µl) were
spotted in 20-µl volumes onto thin-layer chromatography (TLC) plates
(PE Sil G, Whatman; Fisher). Pure arachidonic acid (30 mM, 50 µl;
Sigma) was spotted onto the plate as a chromatography marker. The TLC
plates were chromatographed using a solvent containing hexane:diethyl
ether:glacial acetic acid (80:20:1.8; v/v/v).30
The lane
containing pure arachidonic acid was placed into a chamber containing
iodine vapors and allowed to develop for 5 to 10 minutes to determine
the Rf of pure arachidonic acid.31
The other lanes on the plate (20 x 3.5 cm) were separated, and
each was cut into 10 equal sections (2 cm) for scintillation counting.
Statistical Analysis
The SEM of Staphylococcus per cornea or contact lens
as well as the SEM for CFU or counts per minute (cpm) per assay
reaction were determined using a Statistical Analysis Systems
program.32
Statistical analysis was performed using a
one-way nested analysis of variance on each group. Protected
t-tests were then determined between least square means
derived from each variance analysis on each group. P
0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
In Vitro Killing of Bacteria by Rabbit Tears
To determine whether a host defense against
Staphylococcus was associated with the tear film, the
survival of Staphylococcus in rabbit tears was analyzed.
Bacteria in TSB (7.0 log CFU, initial concentration) were mixed (1:1;
v/v) with tears or saline and incubated at 33° or 37°C for 4 hours.
Samples of bacteria in tears incubated at 33°C demonstrated a 4 log
reduction in CFUs compared with bacteria incubated in saline at 33°C
(3.99 ± 0.27 vs. 8.34 ± 0.20 log CFU, respectively;
P
0.001). The bacteria incubated with saline at
37°C for 4 hours contained a similar quantity of bacteria as those
incubated with tears at 37°C (7.82 ± 0.12 vs. 6.84 ± 0.32
log CFU, respectively; P = 0.0994).
To determine the rate of bacterial killing by tears at 33°C, a mixture of tears and bacterial culture, as well as a mixture of saline and bacterial culture, was incubated at 33°C and assayed periodically (Fig. 2) . The results show that the bacterial killing was minimal at 0.5 hours, but was clearly evident by 1 hour and became extensive by 4 hours compared with the saline control at each time point.
|
|
Release of Radioactive Arachidonic Acid from S.
aureus by PLA2 or Tears
The activity of pure PLA2 or rabbit tears in cleaving arachidonic
acid from bacterial membranes was tested using
14C-labeled S. aureus. Bacteria
incubated without PLA2 or rabbit tears did not show significant
bacterial membrane cleavage as measured by cpm released from the
bacteria. However, S. aureus incubated with pure PLA2 (
0.2
U) or with rabbit tears (
2 µl) for 30 minutes at 33°C
demonstrated significant cleavage of bacterial membranes (Fig. 4)
.
|
|
|
2
mM). However, spermidine, an inhibitor of PLA2 activity with less
potency than tetracaine, at a concentration of 1 mM was minimally toxic
for S. aureus, and partial inhibition of the PLA2-mediated
release of arachidonic acid was noted. S. aureus incubated
with a nonlethal quantity of tears (10 µl) and with spermidine (1 mM)
were found to grow to approximately twice the CFU numbers
obtained in tears without spermidine (Table 1) . Bacteria incubated with a lethal quantity of tears (60 µl) were
killed unless spermidine (4 mM) was included. In the presence of
spermidine (4 mM) the bacteria in tears grew to quantities exceeding
that of the controls free of tears.
|
| Discussion |
|---|
|
|
|---|
The defensive role of PLA2 in rabbit tears was overcome by the addition of inhibitors of the PLA2 reaction. These inhibitors significantly reduced the release of arachidonic acid from bacteria incubated in tears and promoted the survival and growth of bacteria in potentially lethal quantities of tears (60 µl). The data do not exclude the possibility that, in addition to PLA2 digestion of bacterial membranes, other components of tears contribute to bacterial killing. However, the data show that PLA2 must be active for the bactericidal reaction to occur.
The results of this study help explain the difference in bacterial survival and growth after inoculation by intrastromal injection as opposed to topical inoculation. Injection of relatively small numbers of S. aureus (100 CFU) into the rabbit corneal stroma (remote from the tear film) results in keratitis characterized by rapid increases in the number of CFU per cornea and by a steady increase in inflammation and tissue damage.18 However, Matoba et al.20 showed that topical inoculation of S. aureus onto scarified rabbit corneas failed to result in keratitis. The present study as well as previous studies from this laboratory26 and from Rhem et al.34 demonstrates that the application of S. aureus onto the rabbit cornea can lead to inflammation. Inflammation noted by this laboratory included chemosis, injection, and accumulation of pus on the corneal surface. Such inflammation could be stimulated at least in part by the release of arachidonic acid during PLA2 digestion of the bacterial inoculum. The release of arachidonic acid could also stimulate inflammation during other ocular infections associated with Staphylococcus such as conjunctivitis or blepharitis. Although inflammation was apparent in previous studies,20 26 34 an increase in bacterial CFUs in the cornea after topical inoculation has not been previously described. In fact, numerous methods to mechanically compromise the cornea before topical inoculation have failed to yield a topical model of Staphylococcus keratitis with extensive bacterial replication.26 The methods tested include enhanced scarification, vertical incisions of various depths into the stroma using a diamond knife, and removal of the epithelium. Pretreatment of the cornea with hydrolytic enzymes and the testing of numerous bacterial strains and growth conditions have also failed to yield an infection in which extensive and rapid bacterial replication followed topical inoculation. The successful infection of the rabbit cornea after inoculation by intrastromal injection and the repeated failures of topical Staphylococcus inoculations each appear appropriate now that the bactericidal potency of PLA2 in the rabbit tear film has been determined.
The killing of Staphylococcus in rabbit tears appeared greater at 33°C than at 37°C. This observation, however, represents the sum of two reactions: the killing of bacteria by PLA2 in tears and the growth of bacteria in a rich medium (TSB) at 37°C. Release of radioactive arachidonic acid from bacterial membranes was as extensive at 37°C as at 33°C, indicating that PLA2 is fully active at 37°C (unpublished finding). Most experiments in the present study were conducted at 33°C because the lower temperature (33°C vs. 37°C) is essentially that of the normal rabbit corneal surface.28
The effect of tears on Staphylococcus survival was clearly concentration dependent. Low volumes of tears mixed with bacteria in buffer resulted in bacterial growth, indicating that tears contain a relatively high concentration of nutrients suitable for bacterial replication. However, at higher tear concentrations the bactericidal properties of tears offset the nutritive effects, and the bacteria were killed. These results are significant because they suggest that even a partial loss of PLA2 activity in the tear film could leave the corneal surface covered with a nutritive layer instead of a bactericidal layer. A loss in the bactericidal activity of PLA2 in tears could be an unrecognized hallmark of some diseases that predispose patients to bacterial infection (e.g., Sjögrens syndrome). If so, the topical application of exogenous PLA2 could represent a prophylactic therapy for such patient populations. Saari et al.35 have suggested that PLA2 of human tears declines with age. This decline of PLA2 could increase the possibility of ocular infection among the elderly.
Two findings of potential significance were that tetracaine inhibits the PLA2 reaction responsible for the killing of bacteria in tears and that tetracaine is itself toxic to S. aureus. Tetracaine is only one topical anesthetic commonly used in ophthalmology that has reported inhibitory activity for PLA2.22 We have found that proparacaine is another topical ocular medication that is inhibitory for PLA2 digestion of bacterial membranes (unpublished finding). These findings imply that the use of an ocular anesthetic inhibitory for PLA2 activity on bacteria could compromise this major host defense of the tear film and precondition the eye to infection with bacteria resistant to the anesthetic. The bactericidal activity of these anesthetics could be an under-recognized yet important factor in avoiding nosocomial ocular infections. Studies are needed to determine the ability of various drugs to inhibit the protective PLA2 reaction, the susceptibility of various ocular bacterial pathogens to the PLA2 activity, and the susceptibility of these ocular pathogens to ocular anesthetics.
This study has demonstrated that bacterial killing in the tear film of rabbits is mediated by PLA2 and that this defense mechanism is apparently of sufficient potency to protect the scarified cornea against topical inoculation of Staphylococcus. Although the data presently available do not exclude the involvement of other host components in the bacterial killing reactions, inhibition of PLA2 activity by spermidine was sufficient to protect bacteria from the lethal effects of tears. Impairment of PLA2 activity by use of drugs inhibitory to this protective enzyme could be a predisposing factor for ocular infections, especially those after surgery or other invasive techniques. Further studies of this protective reaction as a broad-based ocular host defense system are needed to understand the interaction of the tear film with invading bacteria.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by National Eye Institute Grant RO1-EY10974.
Submitted for publication March 19, 2001; revised June 1, 2001; accepted June 7, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Richard J. OCallaghan, Department of Microbiology, Immunology, and Parasitology, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112. rocall{at}lsuhsc.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. C. Turner, M. T. Budak, M. A. M. Akinci, and J. M. Wolosin Comparative Analysis of Human Conjunctival and Corneal Epithelial Gene Expression with Oligonucleotide Microarrays Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2050 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, A. G. Hise, C. M. Kalsow, and E. Pearlman Staphylococcus aureus-Induced Corneal Inflammation Is Dependent on Toll-Like Receptor 2 and Myeloid Differentiation Factor 88 Infect. Immun., September 1, 2006; 74(9): 5325 - 5332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hori, S. J. Spurr-Michaud, C. L. Russo, P. Argueso, and I. K. Gipson Effect of Retinoic Acid on Gene Expression in Human Conjunctival Epithelium: Secretory Phospholipase A2 Mediates Retinoic Acid Induction of MUC16 Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4050 - 4061. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Girgis, J. M. Reed, K. S. Monds, J. J. Dajcs, M. E. Marquart, B. A. Thibodeaux, and R. J. O'Callaghan Pathogenesis of Staphylococcus in the Rabbit Anterior Chamber Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1371 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. H. Hume, N. Cole, A. Parmar, M. E. Tan, Y. Aliwarga, T. Schubert, B. A. Holden, and M. D. P. Willcox Secretory Phospholipase A2 Deposition on Contact Lenses and Its Effect on Bacterial Adhesion Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3161 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Girgis, G. D. Sloop, J. M. Reed, and R. J. O'Callaghan A New Topical Model of Staphylococcus Corneal Infection in the Mouse Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1591 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Girgis, J. J. Dajcs, and R. J. O'Callaghan Phospholipase A2 Activity in Normal and Staphylococcus aureus-Infected Rabbit Eyes Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. H. Hume, J. J. Dajcs, J. M. Moreau, G. D. Sloop, M. D. P. Willcox, and R. J. O'Callaghan Staphylococcus Corneal Virulence in a New Topical Model of Infection Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2904 - 2908. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |